Jasper Therapeutics, Inc.
JSPR · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$18,736 | -$26,723 | -$21,241 | -$24,321 |
| Dep. & Amort. | $229 | $258 | $279 | $245 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $1,424 | $1,817 | $1,811 | $0 |
| Change in WC | -$187 | $8,878 | -$3,884 | $831 |
| Other Non-Cash | $271 | $317 | $193 | $2,111 |
| Operating Cash Flow | -$16,999 | -$15,453 | -$22,842 | -$21,134 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | $0 | -$7 | $0 | -$96 |
| Net Acquisitions | $0 | $0 | $0 | $20 |
| Inv. Purchases | $0 | $0 | $0 | $0 |
| Inv. Sales/Matur. | $0 | $0 | $0 | $0 |
| Other Inv. Act. | $0 | $8 | $4 | $0 |
| Investing Cash Flow | $0 | $1 | $4 | -$76 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | $0 |
| Stock Issued | $514 | $5,940 | $0 | $345 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $27,874 | $223 | $0 | $0 |
| Financing Cash Flow | $28,388 | $6,163 | $0 | $345 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | $11,389 | -$9,289 | -$22,838 | -$20,865 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $39,927 | $49,216 | $72,054 | $92,502 |
| End Cash | $51,316 | $39,927 | $49,216 | $71,637 |
| Free Cash Flow | -$16,999 | -$15,460 | -$22,842 | -$21,230 |